What findings should be assessed during the physical examination of a patient with suspected chronic myeloid leukemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Physical Examination Findings in Chronic Myeloid Leukemia

The physical examination of a patient with suspected CML must focus on spleen and liver size assessment, with splenomegaly being the most characteristic finding, present in the majority of cases 1, 2.

Key Physical Examination Components

Spleen Assessment (Most Critical)

  • Palpate for splenomegaly - this is the hallmark physical finding in CML
  • Spleen enlargement can be massive, extending 8 cm or more below the costal margin 3
  • In advanced cases, splenomegaly may reach 31.9 cm with mass effect on adjacent structures 4
  • Document spleen size in centimeters below the left costal margin, as this measurement is incorporated into prognostic scoring systems (Sokal, Euro, EUTOS, and ELTS scores) 1

Liver Assessment

  • Palpate for hepatomegaly, though this is less common than splenomegaly 1, 2
  • Document liver span if enlarged

General Physical Findings

  • Assess for pallor - anemia is common at presentation 3
  • Check for sternal tenderness - may indicate bone marrow expansion 3
  • Evaluate for signs of bleeding complications (rare but serious):
    • Ecchymoses or petechiae
    • Signs of intracranial hemorrhage (altered mental status, focal neurological deficits)
    • Soft tissue hematomas 5

Important Clinical Context

What You May NOT Find

A common pitfall is assuming all CML patients present with classic findings. Approximately 30% of patients may have minimal or no splenomegaly at diagnosis 6, particularly when:

  • Concurrent vitamin B12 or folate deficiency masks typical features
  • Disease is detected incidentally during routine blood work 4
  • Ineffective erythropoiesis predominates

Prognostic Importance

The spleen size measurement is not merely descriptive - it directly impacts:

  • ELTS score calculation (predicts leukemia-related death) 1
  • Sokal score (most widely used prognostic system) 1
  • Treatment planning and monitoring

Phase Assessment Clues

While physical examination alone cannot distinguish disease phase, certain findings raise concern:

  • Fever and bone pain suggest possible progression to accelerated or blast phase 2
  • Rapidly enlarging spleen despite treatment may indicate disease progression

Examination Sequence

  1. Vital signs - establish baseline stability
  2. General appearance - assess for pallor, signs of systemic illness
  3. Abdominal examination - measure spleen and liver size precisely
  4. Sternal palpation - check for tenderness
  5. Skin examination - look for bleeding manifestations
  6. Brief neurological assessment - if any bleeding concerns

The physical examination provides critical baseline data that complements laboratory and molecular diagnostics, with spleen size being the single most important physical finding for both diagnosis and prognosis 1, 2.

References

Guideline

chronic myeloid leukemia, version 2.2021, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2020

Research

Chronic Myeloid Leukaemia In A 14-Year-Old Child: An Unusual Case Report.

Journal of Ayub Medical College, Abbottabad : JAMC, 2022

Research

Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid Leukemia.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2026

Research

Chronic myelogenous leukemia accompanied by megaloblastic anemia showing atypical clinical features.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.